Video

Dr. Crawford on the Drawbacks of PSA Screening

Author(s):

E. David Crawford, MD

E. David Crawford, MD from the University of Colorado Health Sciences Center on the Drawbacks of PSA Screening

Related Videos
VK Gadi, MD, PhD
Komal Jhaveri, MD, FACP
Mark Pegram, MD
David R. Spigel, MD, chief scientific officer, Sarah Cannon Research Institute
Rene Adam, MD, PhD
Timothy Hughes, MD, MBBS, FRACP, FRCPA
Mikkael A. Sekeres, MD, professor, medicine, chief, Division of Hematology, Leukemia Section, the University of Miami Sylvester Comprehensive Cancer Center
Hetty E. Carraway, MD, MBA
Tycel Phillips, MD, MPH
Mazyar Shadman, MD, MPH
Related Content
Fernando Cotait Maluf, MD
June 7th 2024

Pembrolizumab With Platinum-Based Therapy is Safe and Efficacious in PSCC

Neeraj Agarwal, MD
July 17th 2023

FDA Approval Insights: Talazoparib Plus Enzalutamide in HRR Gene–Mutated mCRPC

Stephen J. Freedland, MD
June 5th 2024

Enzalutamide Treatment Suspension Has No Significant Impact on QOL in nmHSPC

Andrew J. Armstrong, MD, MSc
June 15th 2023

FDA Approval Insights: Olaparib Plus Abiraterone in BRCA-Mutated mCRPC

James A. Knight II, MD
May 28th 2024

Broadening Differentials in Brain-Metastatic Prostate Cancer Broadens Diagnostic Horizons

FDA
May 28th 2024

FDA Approval Sought for Use of TLX007-CDx in PSMA PET Imaging of Prostate Cancer